Zoli W - Search Results

1

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.

Ibrahim T, Mercatali L, Sacanna E, Tesei A, Carloni S, Ulivi P, Liverani C, Fabbri F, Zanoni M, Zoli W, Amadori D. Ibrahim T, et al. Among authors: zoli w. Cancer Cell Int. 2012 Nov 22;12(1):48. doi: 10.1186/1475-2867-12-48. Cancer Cell Int. 2012. PMID: 23173568 Free PMC article.

2

Role of efflux pump activity in lapatinib/caelyx combination in breast cancer cell lines.

Vannini I, Zoli W, Fabbri F, Ulivi P, Tesei A, Carloni S, Brigliadori G, Amadori D. Vannini I, et al. Among authors: zoli w. Anticancer Drugs. 2009 Nov;20(10):918-25. doi: 10.1097/CAD.0b013e32833179bf. Anticancer Drugs. 2009. PMID: 19752719

3

Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.

Ibrahim T, Liverani C, Mercatali L, Sacanna E, Zanoni M, Fabbri F, Zoli W, Amadori D. Ibrahim T, et al. Among authors: zoli w. Int J Oncol. 2013 Apr;42(4):1263-70. doi: 10.3892/ijo.2013.1809. Epub 2013 Feb 6. Int J Oncol. 2013. PMID: 23403907

4

[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.

Ibrahim T, Liverani C, Mercatali L, Sacanna E, Zanoni M, Fabbri F, Zoli W, Amadori D. Ibrahim T, et al. Among authors: zoli w. Int J Oncol. 2016 Sep;49(3):1260. doi: 10.3892/ijo.2016.3613. Epub 2016 Jul 6. Int J Oncol. 2016. PMID: 27573164 Free PMC article.

5

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

Ricotti L, Tesei A, De Paola F, Ulivi P, Frassineti GL, Milandri C, Amadori D, Zoli W. Ricotti L, et al. Among authors: zoli w. Clin Cancer Res. 2003 Feb;9(2):900-5. Clin Cancer Res. 2003. PMID: 12576465

6

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Among authors: zoli w. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

7

Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.

Rosetti M, Tesei A, Ulivi P, Fabbri F, Vannini I, Brigliadori G, Amadori D, Bolla M, Zoli W. Rosetti M, et al. Among authors: zoli w. Apoptosis. 2006 Aug;11(8):1321-30. doi: 10.1007/s10495-006-6986-x. Apoptosis. 2006. PMID: 16699954

8

Short interfering RNA directed against the SLUG gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine.

Vannini I, Bonafe M, Tesei A, Rosetti M, Fabbri F, Storci G, Ulivi P, Brigliadori G, Amadori D, Zoli W. Vannini I, et al. Among authors: zoli w. Cell Oncol. 2007;29(4):279-87. doi: 10.1155/2007/540821. Cell Oncol. 2007. PMID: 17641412 Free PMC article.

9

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.

Tesei A, Rosetti M, Ulivi P, Fabbri F, Medri L, Vannini I, Bolla M, Amadori D, Zoli W. Tesei A, et al. Among authors: zoli w. J Transl Med. 2007 Oct 30;5:52. doi: 10.1186/1479-5876-5-52. J Transl Med. 2007. PMID: 17971198 Free PMC article.

10

NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.

Tesei A, Zoli W, Fabbri F, Leonetti C, Rosetti M, Bolla M, Amadori D, Silvestrini R. Tesei A, et al. Among authors: zoli w. Nitric Oxide. 2008 Sep;19(2):225-36. doi: 10.1016/j.niox.2008.04.007. Epub 2008 Apr 22. Nitric Oxide. 2008. PMID: 18472019 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters